BioRePortAP, an electronic clinical record coupled with a data base: An example of its use in a single centre

Acta Reumatologica Portuguesa

Volumn 35, Issue 2, 2010, Pages 176-183

  Campanilho Marques, R ^a   Polido Pereira, J ^b   Rodrigues, A ^b   Ramos, F ^a   Saavedra, M J ^a   Costa, M ^a   Martins, F ^c   Pereira da Silva, J A ^a   Canhao H ^b   Fonseca, J E ^b  

^a Centro Hospitalar Lisboa Norte Hospital de Santa Maria   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c Sociedade Portuguesa de Reumatologia   (Portugal)

Author keywords

Biological therapy; BioReportAP; Portugal; Psoriatic arthritis; Registry

Indexed keywords

EID: 78650445278     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Glandman DD. Psoriatic arthritis. Dermatol Ther 2009; 22: 40-55.
2. Taylor WJ. The epidemiology of psoriatic arthritis. Curr Opin Rheumatol 2002; 14: 98-103.
3. Taylor WJ. Assessment of outcome in psoriatic arthritis. Curr Opin Rheumatol 2004; 16: 350-353.
4. Mease JP. Spondyloarthritits Update: New insights Regarding Classification, Pathophysiology and management. Bull NYU Hosp Jt Dis 2008; 66: 203-209.
5. Mease PJ, Antoni CE, Gladman DD et al. Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 2005; 64: 49-54.
6. Van Gestel AM, Prevoo ML, van't Hof MA et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum 1996; 39: 34-40.
7. Deandrade JR. A seven-day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965; 8: 302-334.
8. Smolen JS, Breedveld FC, Elberl G et al. Validity and reability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 1995; 38: 38-43.
9. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-2291.
10. Calin A, Garrett S, Whitelock H et al. New approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281-2285.
11. Frederiksson T. Severe psoriasis - oral therapy with a new retinoid. Dermatol 1994; 157: 238-244.
12. Gottlieb AB. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison. J Drug Dermatol 2003; 2: 260:266.
13. Fries JF, Kraines RG, Splitz Z et al. Measurement of patient outcomes in arthritis. Arthritis Rheum 1980; 23: 137-145.
14. Olivieri I, Cantini F, Salvarani C et al. Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum 2002; 46: 2964-2967.
15. Schentag CT. Validation and normative data for the 0-10 point scale version of the fatigue severity scale (FSS). Ann Rheum Dis 2000; 43: 177-181.
16. McGonagle D, Emery P, Gibbon W et al. Classification of inflammatory arthritis by enthesistis. Lancet 1998; 352: 1137-1140.
17. Grupo de Estudos de Artrite Reumatóide da Sociedade Portuguesa de Reumatologia. Análise de 376 doentes com artrite reumatóide submetidos a terapêutica biológica registados na base de dados de terapêutica biológica da Sociedade Portuguesa de Reumatologia. Acta Reum Port 2005; 30: 63-71.
18. Grupo de Consensos para as terapêuticas biológicas na Espondilite Anquilosante da Sociedade Portuguesa de Reumatologia. Análise de doentes com espondilite anquilosante submetidos a terapêutica biológica registados na base de dados de terapêutica biológica da Sociedade Portuguesa de Reumatologia. Acta Reum Port 2005; 30: 253-260.
19. João Eurico Fonseca, Helena Canhão, Paulo Reis et al. Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 update. Acta Reum Port 2010; 35: 95-98.
20. Grupo de Consensos para as Terapêuticas biológicas na Espondilite Anquilosante da Sociedade Portuguesa de Reumatologia. Consensos sobre a utilização de antagonistas do TNF na terapêutica da espondilite anquilosante. Acta Reum Port 2005; 30: 155-159.
21. Fonseca JE, Canhão H, Reis P et al. Protocolo de monitorização clínica da artrite reumatóide (PMAR) - revisão de Dezembro de 2007. Acta Reum Port 2007 32: 367-374.
22. Fonseca JE, Lucas H, Canhão H et al. Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors March 2008 update. Acta Reum Port 2008; 33: 77-85.
23. Fonseca JE, Lucas H, Canhão H et al. Recomendações para o diagnóstico e tratamento da tuberculose latente e activa nas doenças inflamatórias articulares candidatas a tratamento com fármacos inibidores do factor de necrose tumoral alfa. Acta Reum Port 2006; 31: 237-245.